Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Prostaglandin E1 (PGE1) is the theoretical cyclooxygenase metabolite of dihomo-γ-linolenic acid.1 Its pharmacology includes vasodilation, hypotension, and anti-platelet activities. The IC50 value of PGE1 for the inhibition of ADP-induced human platelet aggregation is 40 nM.2,3 PGE1 is used to treat male erectile dysfunction and to maintain ductus arteriosus patency in infants.4,5 PGE1 ethyl ester is an esterified form of the free acid which may be more amenable for certain applications.
WARNING This product is not for human or veterinary use.
1. Pharmacokinetics of prostaglandin E1 and its main metabolites after intracavernous injection and short-
2. Antiaggregating potency of E-
3. The hypotensive effect of prostaglandin E1 on hypertensive cases of various types. Prostaglandins 7(2), 99-106 (1974).
4. Treatment of men with erectile dysfunction with transurethral alprostadil. N. Engl. J. Med. 336(1), 1-7 (1997).
5. Prostaglandins and the ductus arteriosus. Annu. Rev. Med. 32, 375-3785 (1981).